Inovio Pharmaceuticals Announces Positive Interim Results in Phase II...
BLUE BELL, Pa., Dec. 6, 2012 -- /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that preliminary results of a phase II clinical trial to treat leukemia with a WT1 DNA...
View ArticlePositive Response from European Regulatory Procedure Supports Approval of...
NYON, Switzerland, December 18, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announces a positive outcome from the European Decentralised Procedure (DCP) for Elvanse® (to be known as...
View ArticleLeukemia Patients Remain in Remission More Than Two Years After Receiving...
Google Download image...
View ArticleInovio Pharmaceuticals Announces Positive Interim Results in Phase II...
BLUE BELL, Pa., Dec. 6, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that preliminary results of a phase II clinical trial to treat leukemia with a WT1 DNA vaccine...
View ArticleNew Quintiles Resource for Cancer Patients Wins Third Health Award for...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cancer patients looking for clinical trials of oncology therapies in their own areas plus information and news to help them understand the disease and...
View ArticleWhat mechanism generates our fingers and toes?
Genetic studies at the IRCM confirm a mathematical model MONTREAL, Dec. 14, 2012 /CNW Telbec/ - Dr. Marie Kmita and her research team at the IRCM contributed to a multidisciplinary research project...
View ArticleAmgen Highlights Data To Be Presented At American Society of Hematology...
My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about AMGN Google...
View ArticleScientists discover intriguing new gene link to breast and ovarian cancer...
(Source: University of London) Sunday 16 December 2012 A team of researchers led from The Institute of Cancer Research, London, have found that mutations in a gene called PPM1D are linked to an...
View ArticleUpdate on SCIB1 Phase 1/2 clinical trial 6th Dec 2012 (Scancell Holdings plc)
Preliminary evidence of immune response and clinical benefit. Scancell Holdings Plc, (AIM:SCLP), the developer of therapeutic cancer vaccines, is pleased to announce preliminary results from Part 1 of...
View ArticleInfinity Reports IPI-145 Phase 1 Data Showing Clinical Activity in B-Cell...
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company’s potent, oral inhibitor of...
View ArticleFred Hutchinson Cancer Research Center Partners With GlaxoSmithKline to...
Collaboration represents first U.S. institution chosen to participate in GSK academic-industry partnership Google...
View ArticleUTHealth awarded millions for cancer research and prevention (The University...
(Source: The University of Texas System) UTHealth faculty member Hua Xu, Ph.D., is using information extracted from electronic health records to explore new cancer treatments. HOUSTON - (Dec. 17,...
View ArticleBiogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug...
Biogen Idec (NASDAQ: BIIB) announced today that it has created a new research consortium in collaboration with several leading academic research centers that will leverage a range of scientific...
View ArticleGentium To Initiate Clinical Development in Japan and Expand Named-Patient...
VILLA GUARDIA (COMO), Italy, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced the Company's entry into an agreement with the National University...
View ArticleCancer stem cells isolated from kidney tumors
"In earlier studies, cancer stem cells were isolated from adult cancers of the breast, pancreas and brain but so far much less is known about stem cells in paediatric cancers," remarked Professor...
View ArticleInfinity Reports IPI-145 Phase 1 Data Showing Clinical Activity in B-Cell...
– Company Provides Anticipated PI3K Program Milestones – – Company to Host Investor Reception and Webcast Monday Evening – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ:...
View ArticleSMC Heads-Up: Science funding paper, Xmas hours, food prices
Friday, 14 December 2012, 3:17 pm Press Release: Science Media Centre Issue 211 14 - 20 December In This Issue Quick Links Peer review - have we got it right? What role should the peer review process...
View ArticleGenotype predicts treatment related mortality (TRM) in African-American and...
AML, the second most common form of leukemia in children, is a blood cancer in which the bone marrow makes a large number of abnormal white blood cells that crowd out other healthy blood cells over...
View ArticleAlliance for Cancer Gene Therapy Funds Promising Leukemia Study – Patients...
Clinical Trial Involves Exciting Results in 12 Patients – Including Two Children STAMFORD, Conn.--(BUSINESS WIRE)--Alliance for Cancer Gene Therapy (ACGT), the nation’s only non-profit organization...
View Article
